Clarivate for Life Sciences & Healthcare

Join Clarivate experts Madhurima Datta and Reena V Gupta at CPHI India 2024, where innovation meets opportunity in the pharmaceutical industry from November 26-28 in Delhi. Connect with our team to explore the latest industry trends, network with key leaders, and discuss collaborative opportunities for advancing the future of pharma. Discover how Clarivate’s market-leading intelligence and transformative data technology can shape the industry by booking a meeting with our team here: https://lnkd.in/eq3kbvT4 #CPhIIndia #Pharmaceuticals #Networking #Innovation #Collaboration #pharma

Join the Clarivate team— Hozana Castillo, James Fedorow and George Naish—at AusBiotech 2024, taking place now through November 1 at the Melbourne Convention & Exhibition Centre. AusBiotech is the premier international gathering for the Australian life sciences community, dedicated to showcasing how biotechnology continues to unlock remarkable potential for advancing human health. Don’t miss this opportunity to connect in person, engage with cutting-edge programming, and collaborate on initiatives that will spotlight Australian life sciences on the global stage. Together, let’s explore innovative solutions in biotechnology, medical devices, and more. Visit us at booth #64! Learn more: https://lnkd.in/eBB_WT3 #LifeSciences #Biotechnology #AusBiotech2024 #Clarivate #Networking #Innovation #Melbourne #ThinkForward

Explore the latest insights, trends and innovations in the medical technology sector in our dedicated MedTech Resource Center. Whether you're looking for in-depth reports, market intelligence, or expert analyses, our resource center offers a wealth of information to help you stay ahead in this rapidly evolving industry. Join the conversation and discover how you can leverage data and insights to drive innovation in your organization, here: https://lnkd.in/eWACgydi #Medtech #ThoughtLeadership #Medicaltechnology #MedicalDevices

Meet the Clarivate team— Alison Isherwood, Brigitte Moore, Catherine Bottomley, Ciaran Cassidy, Ilias Paniaras, Nicki Hoskins, Richard Massey, Sarah Knight, Sonia Alesso, Stacey Chang-Douglass, and Sunita Nair—at ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2024, held from November 17 to 20 in Barcelona. Join us as we connect with global healthcare leaders in Health Economics and Outcomes Research (HEOR). Engage with researchers, policymakers, and industry experts as we delve into the latest trends and advancements in HEOR. Don’t miss poster presentations by Alison Isherwood, Brigitte Moore, Catherine Bottomley, Nicki Hoskins, Stacey Chang-Douglass, and Sunita Nair. Book a meeting with our team or visit us at booth #701. #HealthcareInnovation #HEOR #HealthEconomics #Networking #ISPOR2024

Are cutaneous manifestations in patients with dermatomyositis only skin deep? Dermatomyositis (DM) is a rare autoimmune disease that significantly impacts patients’ quality of life. This study, co-authored by experts from Clarivate, Pfizer and University of Pittsburgh Medical Centre, explores the cutaneous manifestations of DM, revealing how symptoms like rash, itch, and dry skin affect daily life and emotional wellbeing. With patient interviews and expert analysis, this research highlighted unmet treatment needs and explored the suitability of existing clinical outcome assessments. Read the manuscript here: https://lnkd.in/e__ayf_p #PatientCare #SkinHealth #Dermatomyositis #HealthcareResearch

Meet Clarivate experts - Mohamed Salmawy, Strategic Account Manager, Derrick Burgman, Account Manager, Channavy Sem, Major Account Manager, Oliver Sless, Senior Account Manager- at the 36th Annual Transcatheter Cardiovascular Therapeutics Conference now through October 30 in Washington, D.C. This year’s theme 'From Intervention to Prevention’ highlights the transformation of cardiovascular care by integrating preventive measures with interventional treatments. Join us for discussions and presentations that emphasize proactive strategies in combating cardiovascular diseases—from lifestyle modifications to early detection techniques. Discover innovative approaches that are set to revolutionize patient care. Don’t miss the opportunity to gain insights into market-leading intelligence solutions and transformative data technology that can shape the future of cardiovascular medicine. Book a meeting with our team here: https://lnkd.in/e6Tv7rRX #TCT2024 #CardioVascular #Medtech

Join the Clarivate team— Hozana Castillo, James Fedorow, and George Naish—at AusBiotech 2024 from October 30 to November 1 at the Melbourne Convention & Exhibition Centre! As the premier international gathering for the Australian life sciences community, AusBiotech showcases how biotechnology is unlocking immense potential for improving human health. Don’t miss this opportunity to network, engage with cutting-edge programming and collaborate on initiatives that will elevate Australian life sciences on the global stage. Together, we’ll explore innovative solutions across biotechnology, commercialisation and more. Visit us at booth #64! Learn more here: https://lnkd.in/eBB_WT3 #LifeSciences #Biotechnology #AusBiotech2024 #Clarivate #Networking #Innovation #Melbourne #ThinkForward

Join Clarivate experts - Mohamed Salmawy, Strategic Account Manager, Derrick Burgman, Account Manager, Channavy Sem, Major Account Manager, Oliver Sless, Senior Account Manager - at the 36th Annual Transcatheter Cardiovascular Therapeutics Conference, taking place from October 27-30 in Washington, D.C., under the theme 'From Intervention to Prevention.' This year's event focuses on transforming cardiovascular care by integrating preventive measures with interventional treatments. Engage in groundbreaking discussions and presentations that underscore the critical role of proactive strategies in combating cardiovascular diseases—from lifestyle modifications to early detection techniques. Discover innovative approaches poised to revolutionize patient care. Gain market leading intelligence solutions and transformative data technology to shape the future of cardiovascular medicine, by booking a meeting with the Clarivate team, here: https://lnkd.in/e6Tv7rRX Clarivate Market Insight Research reports are curated by over 40 analysts covering 80-plus medical device markets across more than 50 countries globally. Our integrated MedTech intelligence datasets span R&D and commercialization life cycle, along with other industry sources. Check out our Cardiovascular reports across global markets, here: https://lnkd.in/eb_wF2q2 #TCT2024 #Cardiology #PreventiveCare #HealthcareInnovation #PatientCare #CardioVascular #Medtech Cardiovascular Research Foundation

#webinar As leading U.S. health insurers quietly acquire provider assets, the balance of power in healthcare is shifting. This transformation is influencing how Integrated Delivery Networks (IDNs) approach patient care, referral streams, and provider networks. In our upcoming webinar with Fierce Pharma, Clarivate experts - Matthew Arnold, Principal Analyst, Mark Cherry, Lead Healthcare Research & Data Analyst Content, Renée Burnham, Manager, Healthcare Research & Data Analytics Content, Bill Melville, Lead Healthcare Research & Data Analyst – will discuss the latest strategies employed by major players in the industry. The panel will examine how IDNs are standing out amid consolidation, with a focus on nonprofit IDNs and academic medical centers reshaping regional healthcare. Experts will also discuss which organizational profiles are best positioned to capture patient volume and how traditional players can collaborate with disruptors for shared success. Register here: https://lnkd.in/dT59y48m #Healthcare #ValueBasedCare #LifeSciences #HealthcareInnovation

The growing interest in Middle Meningeal Artery Embolization for chronic subdural hematoma is fueled by encouraging early results from the EMBOLISE, STEM, and MAGIC-MT trials. With a projected 13.6% global growth in these procedures from 2023 to 2028, it’s clear this innovative treatment is gaining momentum. In developed markets, expect to see more use of specialty liquid embolics, while cost-conscious regions may lean towards embolic glues and PVA particles. For a rundown of key trends, clinical trial updates, and manufacturers to watch, click here: https://lnkd.in/eT6-Y4kx